Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz
Clinical trial NCT05330273 · COMPLETED
Trial details
- NCT number
- NCT05330273
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2022-11-22
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.